310 related articles for article (PubMed ID: 27448298)
1. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
3. FOXN3 suppresses the growth and invasion of papillary thyroid cancer through the inactivation of Wnt/β-catenin pathway.
Zhao C; Mo L; Li C; Han S; Zhao W; Liu L
Mol Cell Endocrinol; 2020 Sep; 515():110925. PubMed ID: 32619584
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of TRIM44 inhibits the proliferation and invasion in papillary thyroid cancer cells through suppressing the Wnt/β-catenin signaling pathway.
Zhou Z; Liu Y; Ma M; Chang L
Biomed Pharmacother; 2017 Dec; 96():98-103. PubMed ID: 28965013
[TBL] [Abstract][Full Text] [Related]
5. FOXE1 supports the tumor promotion of Gli2 on papillary thyroid carcinoma by the Wnt/β-catenin pathway.
Ma J; Huang X; Li Z; Shen Y; Lai J; Su Q; Zhao J; Xu J
J Cell Physiol; 2019 Aug; 234(10):17739-17748. PubMed ID: 30793770
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of CSN6 attenuates papillary thyroid carcinoma progression by reducing Wnt/β-catenin signaling and sensitizes cancer cells to FH535 therapy.
Wen D; Liao T; Ma B; Qu N; Shi RL; Lu ZW; Wang YL; Wei WJ; Ji QH
Cancer Med; 2018 Feb; 7(2):285-296. PubMed ID: 29341469
[TBL] [Abstract][Full Text] [Related]
7. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637.
Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X
Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928
[TBL] [Abstract][Full Text] [Related]
8. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling.
Wang X; Lu X; Geng Z; Yang G; Shi Y
J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866
[TBL] [Abstract][Full Text] [Related]
9. MiR-146b-5p promotes metastasis and induces epithelial-mesenchymal transition in thyroid cancer by targeting ZNRF3.
Deng X; Wu B; Xiao K; Kang J; Xie J; Zhang X; Fan Y
Cell Physiol Biochem; 2015; 35(1):71-82. PubMed ID: 25547151
[TBL] [Abstract][Full Text] [Related]
10. SOX18 exerts tumor-suppressive functions in papillary thyroid carcinoma through inhibition of Wnt/β-catenin signaling.
Geng Q; Deng H; Fu J; Cui F
Exp Cell Res; 2020 Nov; 396(1):112249. PubMed ID: 32858034
[TBL] [Abstract][Full Text] [Related]
11. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway.
Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H
Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic regulation of Wnt signaling pathway gene SRY-related HMG-box 17 in papillary thyroid carcinoma.
Li JY; Han C; Zheng LL; Guo MZ
Chin Med J (Engl); 2012 Oct; 125(19):3526-31. PubMed ID: 23044318
[TBL] [Abstract][Full Text] [Related]
13. Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.
Gilbert-Sirieix M; Makoukji J; Kimura S; Talbot M; Caillou B; Massaad C; Massaad-Massade L
PLoS One; 2011; 6(7):e22280. PubMed ID: 21814573
[TBL] [Abstract][Full Text] [Related]
14. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2.
Xue KC; Hu DD; Zhao L; Li N; Shen HY
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989
[TBL] [Abstract][Full Text] [Related]
15. PATZ1 acts as a tumor suppressor in thyroid cancer via targeting p53-dependent genes involved in EMT and cell migration.
Chiappetta G; Valentino T; Vitiello M; Pasquinelli R; Monaco M; Palma G; Sepe R; Luciano A; Pallante P; Palmieri D; Aiello C; Rea D; Losito SN; Arra C; Fusco A; Fedele M
Oncotarget; 2015 Mar; 6(7):5310-23. PubMed ID: 25595894
[TBL] [Abstract][Full Text] [Related]
16. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.
Li R; Liu J; Li Q; Chen G; Yu X
Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618
[TBL] [Abstract][Full Text] [Related]
17. ZNRF3 acts as a tumour suppressor by the Wnt signalling pathway in human gastric adenocarcinoma.
Zhou Y; Lan J; Wang W; Shi Q; Lan Y; Cheng Z; Guan H
J Mol Histol; 2013 Oct; 44(5):555-63. PubMed ID: 23504200
[TBL] [Abstract][Full Text] [Related]
18. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1.
Ma S; Jia W; Ni S
Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661
[TBL] [Abstract][Full Text] [Related]
19. ZnRF3 Induces Apoptosis of Gastric Cancer Cells by Antagonizing Wnt and Hedgehog Signaling.
Qin H; Cai A; Xi H; Yuan J; Chen L
Cell Biochem Biophys; 2015 Nov; 73(2):361-367. PubMed ID: 27352324
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-146a targets PRKCE to modulate papillary thyroid tumor development.
Zhang X; Li D; Li M; Ye M; Ding L; Cai H; Fu D; Lv Z
Int J Cancer; 2014 Jan; 134(2):257-67. PubMed ID: 23457043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
